03 November 2024 : Database Analysis
Impact of Tigecycline on Coagulation in Severe Infections and Effect of Vitamin K1 Intervention: A Retrospective Single-Center Analysis
Haiyan Sun12ABCDEFG, Xianqing Meng3BDE, Xupeng Shao1BCF, Liyun Duan1DF, Kailiang Fan1ACFG*DOI: 10.12659/MSM.944778
Med Sci Monit 2024; 30:e944778
Figure 3 Age Distribution. With increasing age, the number of people with coagulopathy using tigecycline in both groups (H-D group, high-dose group; N-D group, normal-dose group) increased, peaking at 81–90 years. The figure was created using GraphPad Prism version 9.0.0 (GraphPad Software, Inc, La Jolla, CA, USA).